<HTML>
<HEAD>
<TITLE>CARN FORM S-8 REGISTRATION STATEMENT</TITLE>
</HEAD>
<BODY>
<HR>

<FONT SIZE=2>
<P></P>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH="100%">
<TR><TD WIDTH="66%" VALIGN="TOP">
<FONT SIZE=2><P>As filed with the Securities and Exchange Commission on January 23, 2008 </FONT></TD>
<TD WIDTH="34%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="RIGHT"> Registration Statement No. 333-<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U></FONT></TD>
</TR>
</TABLE>
<P></P>
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-TOP: black 1pt solid"></DIV>
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: black 1pt solid"></DIV>
<FONT SIZE=2><P ALIGN="CENTER"></P>
</FONT><B><FONT FACE="Times New Roman TUR,Times New Roman"><P ALIGN="CENTER">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
</B>Washington, D.C.  20549</P>
</FONT><FONT FACE="Times New Roman TUR,Times New Roman" SIZE=2><P ALIGN="CENTER"></P>
</FONT><B><FONT FACE="Times New Roman TUR,Times New Roman"><P ALIGN="CENTER">FORM S-8<BR>
</B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933</P>
</FONT><B><FONT SIZE=2><P ALIGN="CENTER"></P>
</FONT><P ALIGN="CENTER">CARRINGTON LABORATORIES, INC.<BR>
</B><FONT SIZE=2>(Exact name of registrant as specified in its charter)</P>
<P ALIGN="CENTER"></P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH="100%">
<TR><TD WIDTH="35%" VALIGN="TOP">
<B><FONT SIZE=2><P ALIGN="CENTER">Texas<BR>
</B>(State or other jurisdiction<BR>
of incorporation or organization)</P>
<B><P ALIGN="CENTER"></B></FONT></TD>
<TD WIDTH="29%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="35%" VALIGN="TOP">
<B><FONT SIZE=2><P ALIGN="CENTER">75-1435663<BR>
</B>I.R.S. Employer Identification No.)</FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP">
<B><FONT SIZE=2><P ALIGN="CENTER">2001 Walnut Hill Lane<BR>
Irving, Texas<BR>
</B>(Address of principal executive offices)</FONT></TD>
<TD WIDTH="29%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="35%" VALIGN="TOP">
<B><FONT SIZE=2><P ALIGN="CENTER">75038<BR>
</B>(Zip Code)</FONT></TD>
</TR>
</TABLE>

<B><FONT SIZE=2>
</FONT><FONT SIZE=2><P ALIGN="CENTER">Carrington Laboratories, Inc. 2004 Stock Option Plan<BR>
</B></FONT><FONT SIZE=2> (Full title of the Plan)</P>
<B><P ALIGN="CENTER"></P>
</FONT><FONT SIZE=2><P ALIGN="CENTER">Robert W. Schnitzius<BR>
Chief Financial Officer<BR>
Carrington Laboratories, Inc.<BR>
2001 Walnut Hill Lane<BR>
Irving, Texas 75038<BR>
(972) 518-1300<BR>
</B>(Name, address and telephone number of agent for service)</P>
<B><P ALIGN="CENTER"></P>
</B><P ALIGN="CENTER">Copy to:<BR>
<B>Peter A. Lodwick, Esq.<BR>
Wesley P. Williams<BR>
Thompson &amp; Knight L.L.P.<BR>
1700 Pacific Avenue, Suite 3300<BR>
Dallas, Texas 75201<BR>
(214) 969-1700</P>
</FONT><FONT SIZE=2><P ALIGN="CENTER"></P>
</B></FONT><FONT SIZE=2><P ALIGN="CENTER">CALCULATION OF REGISTRATION FEE
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-TOP: black 1pt solid"></DIV>
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: black 1pt solid"></DIV>
</P></B></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH="100%">
<TR><TD WIDTH="20%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">Title of <BR>
securities to <BR>
be registered<BR>
</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">Amount <BR>
to be <BR>
registered <BR>
</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">Proposed maximum<BR>
offering price <BR>
per share<BR>
 </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">Proposed <BR>
maximum aggregate <BR>
offering price<BR>
 </FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">Amount <BR>
of <BR>
registration fee<BR>
</FONT></TD>
</TR>
<TR><TD WIDTH="20%" VALIGN="TOP">
<hr width="100%" color=black noshade size="1"></TD>
<TD WIDTH="18%" VALIGN="TOP">
<hr width="100%" color=black noshade size="1"></TD>
<TD WIDTH="20%" VALIGN="TOP">
<hr width="100%" color=black noshade size="1"></TD>
<TD WIDTH="20%" VALIGN="TOP">
<hr width="100%" color=black noshade size="1"></TD>
<TD WIDTH="21%" VALIGN="TOP">
<hr width="100%" color=black noshade size="1"></TD>
</TR>
<TR><TD WIDTH="20%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">Common Stock,<BR>
par value<BR>
$.01 per share</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">1,500,000<BR>
shares (1)(2)</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">$0.37 (3)</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">$555,000 (3)</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">$21.81 (4)</FONT></TD>
</TR>
<TR><TD WIDTH="20%" VALIGN="TOP">
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-TOP: black 1pt solid"></DIV>
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: black 1pt solid"></DIV>
<TD WIDTH="18%" VALIGN="TOP">
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-TOP: black 1pt solid"></DIV>
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: black 1pt solid"></DIV>
<TD WIDTH="20%" VALIGN="TOP">
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-TOP: black 1pt solid"></DIV>
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: black 1pt solid"></DIV>
<TD WIDTH="20%" VALIGN="TOP">
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-TOP: black 1pt solid"></DIV>
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: black 1pt solid"></DIV>
<TD WIDTH="21%" VALIGN="TOP">
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-TOP: black 1pt solid"></DIV>
<DIV style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: black 1pt solid"></DIV>
</TR>
</TABLE>
</P>

<FONT SIZE=2></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH="100%">
<TR><TD WIDTH="5%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">(1)</FONT></TD>
<TD WIDTH="95%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">Pursuant to Rule 416 promulgated under the Securities Act, the offering and sale of shares issuable upon any stock split, stock dividend or similar transaction with respect to these shares are also being registered hereunder.</FONT></TD>
</TR>
<TR><TD WIDTH="5%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">(2)</FONT></TD>
<TD WIDTH="95%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">Includes an indeterminate number of preferred share purchase rights issuable pursuant to the Registrant's shareholder rights agreement, which rights will be transferable only with  shares of Common Stock registered hereunder and under the Prior Registration Statement (as defined in Note (4) below) and issued pursuant to the Registrant's 2004 Stock Option Plan, as amended (the &quot;Plan&quot;).  (See &quot;Explanatory Note.&quot;)</FONT></TD>
</TR>
<TR><TD WIDTH="5%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">(3)</FONT></TD>
<TD WIDTH="95%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">Estimated solely for the purpose of determining the registration fee pursuant to Rule 457(h) under the Securities Act of 1933, as amended (the &quot;Securities Act&quot;), on the basis of the average of the high and low prices for the Common Stock on January 18, 2008.  </FONT></TD>
</TR>
<TR><TD WIDTH="5%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">(4)</FONT></TD>
<TD WIDTH="95%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">Pursuant to Rule 429 under the Securities Act, a combined prospectus, relating to the 1,500,000 shares registered hereby and the 500,000 shares registered pursuant to the Registration Statement on Form S-8 (Registration No. 333-118303) filed with the Securities and Exchange Commission on August 17, 2004 relating to the Plan, (the &quot;Prior Registration Statement&quot;), will be delivered to Plan participants in accordance with Form S-8 and Rule 428 under the Securities Act.  (See &quot;Explanatory Note.&quot;)</FONT></TD>
</TR>
</TABLE>

<FONT SIZE=2><P ALIGN="JUSTIFY"></P>
</FONT>
<HR>
<P></P>
<B><FONT SIZE=2><P ALIGN="CENTER">EXPLANATORY NOTE</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The contents of Form S-8 Registration Statement No. 333-118303 relating to the Carrington Laboratories, Inc. (the &quot;Registrant&quot;) 2004 Stock Option Plan, as amended (the &quot;Plan&quot;), and filed by the Registrant with the Securities and Exchange Commission on August 17, 2004 (the &quot;Prior Registration Statement&quot;), including all documents incorporated by reference in the Prior Registration Statement, are incorporated herein by reference pursuant to General Instruction E to Form S-8.  </P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The purpose of this Registration Statement is to register 1,500,000 additional shares of Common Stock of the Registrant for offer and sale pursuant to the Plan.  Pursuant to Rule 429 under the Securities Act, this Registration Statement constitutes a post-effective amendment to the Prior Registration Statement, and a combined prospectus relating to the 1,500,000 shares of Common Stock registered pursuant to this Registration Statement and the 500,000 shares of Common Stock registered pursuant to the Prior Registration Statement will be delivered to Plan participants in accordance with Form S-8 and Rule 428 of the Securities Act.</P>
<P ALIGN="JUSTIFY"></P>
<B><P ALIGN="CENTER">PART II</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="CENTER">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</P>
<P ALIGN="JUSTIFY"></P>
</B></FONT><FONT FACE="Times New Roman TUR,Times New Roman" SIZE=2><P ALIGN="JUSTIFY">Item 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Documents Incorporated by Reference</P>
</U><I><P ALIGN="JUSTIFY"></P>
</I><P ALIGN="JUSTIFY">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The contents of the Prior Registration Statement, including the documents incorporated by reference therein, are incorporated by reference in this Registration Statement.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">Item 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exhibits</P>
</U><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to the exhibits incorporated by reference to the exhibits filed with or incorporated by reference into the Prior Registration Statement, the exhibits listed in the accompanying Index to Exhibits are filed as a part of this Registration Statement.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="CENTER">[Signature Page Follows]</P>
</FONT><FONT SIZE=2><P ALIGN="CENTER"></P>
<HR>
<P></P>
<B><P ALIGN="CENTER">SIGNATURES</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Irving, State of Texas as of January 22, 2008.</P>
<P ALIGN="JUSTIFY"></P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH="100%">
<TR><TD WIDTH="52%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="48%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=2><P ALIGN="JUSTIFY">CARRINGTON LABORATORIES, INC.</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=21><P></P></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=21><P></P></TD>
<TD WIDTH="44%" VALIGN="TOP" HEIGHT=21><P></P></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="44%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">By:&nbsp;&nbsp;<U>/s/ Carlton E. Turner
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U></FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="44%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Carlton E. Turner, Ph.D., D.Sc.</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="44%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;President and Chief Executive Officer</FONT></TD>
</TR>
</TABLE>

<FONT SIZE=2><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.  The undersigned persons hereby constitute and appoint Carlton E. Turner and Robert W. Schnitzius, or either of them, as our true and lawful attorneys-in-fact with full power to execute in our names and on our behalf, in the capacities indicated below, any and all amendments to this Registration Statement and the Prior Registration Statement to be filed with the Securities and Exchange Commission and hereby ratify and confirm all that such attorneys-in-fact shall lawfully do or cause to be done by virtue hereof.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY"></P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH="100%">
<TR><TD WIDTH="32%" VALIGN="TOP">
<U><FONT SIZE=2><P ALIGN="CENTER">SIGNATURE</U></FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="40%" VALIGN="TOP">
<U><FONT SIZE=2><P ALIGN="CENTER">CAPACITY IN WHICH SIGNED</U></FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<U><FONT SIZE=2><P ALIGN="CENTER">DATE</U></FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT SIZE=2><P><BR>
<U>/s/ Carlton E. Turner</U><BR>
Carlton E. Turner,
Ph.D., D.Sc.</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="40%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
President, Chief Executor Officer and<BR>
Director (principal executive officer)</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
January 22, 2008</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT SIZE=2><P><BR>
<U>/s/ Robert W. Schnitzius</U><BR>
Robert W. Schnitzius</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="40%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
Chief Financial Officer and Secretary <BR>
(principal financial and accounting officer)</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
January 22, 2008</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT SIZE=2><P><BR>
<U>/s/ Ronald R. Blanck</U><BR>
Ronald R. Blanck, D.O.</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="40%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
Director</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
January 22, 2008</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT SIZE=2><P><BR>
<U>/s/ R. Dale Bowerman</U><BR>
R. Dale Bowerman</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="40%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
Director</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
January 22, 2008</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT SIZE=2><P><BR>
<U>/s/ George DeMott</U><BR>
George DeMott</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="40%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
Director</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
January 22, 2008</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT SIZE=2><P><BR>
<U>/s/ Thomas J. Marquez</U><BR>
Thomas J. Marquez</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="40%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
Director</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
January 22, 2008</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT SIZE=2><P><BR>
<U>/s/ Alex McPherson</U><BR>
Alex McPherson, M.D., Ph.D.</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="40%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
Director</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
January 22, 2008</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT SIZE=2><P><BR>
<U>/s/ Edwin Meese, III</U><BR>
Edwin Meese, III</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="40%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
Director</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER"><BR>
January 22, 2008</FONT></TD>
</TR>
</TABLE>
<P ALIGN="CENTER"></P>
<HR>
<FONT FACE="Times New Roman TUR,Times New Roman" SIZE=2>
<P ALIGN="CENTER"></P>
</FONT><FONT SIZE=2><P ALIGN="CENTER">INDEX TO EXHIBITS</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH="100%">
<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=3>
<U><FONT SIZE=2><P>Exhibit Number</U></FONT></TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">
<U><FONT SIZE=2><P>Exhibit</U></FONT></TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">
<FONT SIZE=2><P>4.1</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">
<FONT SIZE=2><P>Carrington Laboratories, Inc. 2004 Stock Option Plan, as amended.</FONT></TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">
<FONT SIZE=2><P>5.1</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">
<FONT SIZE=2><P>Opinion of Thompson &amp; Knight L.L.P.</FONT></TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">
<FONT SIZE=2><P>23.1</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">
<FONT SIZE=2><P>Consent of Weaver and Tidwell, L.L.P.</FONT></TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">
<FONT SIZE=2><P>23.2</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">
<FONT SIZE=2><P>Consent of Grant Thornton LLP.</FONT></TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">
<FONT SIZE=2><P>23.3</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">
<FONT SIZE=2><P>Consent of Thompson &amp; Knight L.L.P. (included in Exhibit 5.1).</FONT></TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="8%" VALIGN="TOP">
<FONT SIZE=2><P>24.1</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="85%" VALIGN="TOP">
<FONT SIZE=2><P>Power of Attorney (included on the signature page of this Registration Statement).</FONT></TD>
</TR>
</TABLE>
</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "cli012308s8.htm", "description": "FORM S-8 REGISTRATION STATEMENT", "secsgml_size_bytes": 19038}]
{"company-data": {"conformed-name": "CARRINGTON LABORATORIES INC /TX/", "cik": "0000718007", "assigned-sic": "2844", "irs-number": "751435663", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-148822", "film-number": "08545361"}, "business-address": {"street1": "2001 WALNUT HILL LANE", "city": "IRVING", "state": "TX", "zip": "75038", "phone": "972-518-1300"}, "mail-address": {"street1": "2001 WALNUT HILL LANE", "city": "IRVING", "state": "TX", "zip": "75038"}, "former-company": {"former-conformed-name": "AVACARE INC", "date-changed": "19860521"}}
CARN FORM S-8 REGISTRATION STATEMENT
As filed with the Securities and Exchange Commission on January 23, 2008
Registration Statement No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
CARRINGTON LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Texas
(State or other jurisdiction
of incorporation or organization)
75-1435663
I.R.S. Employer Identification No.)
2001 Walnut Hill Lane
Irving, Texas
(Address of principal executive offices)
75038
(Zip Code)
Carrington Laboratories, Inc. 2004 Stock Option Plan
(Full title of the Plan)
Robert W. Schnitzius
Chief Financial Officer
Carrington Laboratories, Inc.
2001 Walnut Hill Lane
Irving, Texas 75038
(972) 518-1300
(Name, address and telephone number of agent for service)
Copy to:
Peter A. Lodwick, Esq.
Wesley P. Williams
Thompson & Knight L.L.P.
1700 Pacific Avenue, Suite 3300
Dallas, Texas 75201
(214) 969-1700
CALCULATION OF REGISTRATION FEE
Title of
securities to
be registered
Amount
to be
registered
Proposed maximum
offering price
per share
Proposed
maximum aggregate
offering price
Amount
of
registration fee
Common Stock,
par value
$.01 per share
1,500,000
shares (1)(2)
$0.37 (3)
$555,000 (3)
$21.81 (4)
(1)
Pursuant to Rule 416 promulgated under the Securities Act, the offering and sale of shares issuable upon any stock split, stock dividend or similar transaction with respect to these shares are also being registered hereunder.
(2)
Includes an indeterminate number of preferred share purchase rights issuable pursuant to the Registrant's shareholder rights agreement, which rights will be transferable only with  shares of Common Stock registered hereunder and under the Prior Registration Statement (as defined in Note (4) below) and issued pursuant to the Registrant's 2004 Stock Option Plan, as amended (the "Plan").  (See "Explanatory Note.")
(3)
Estimated solely for the purpose of determining the registration fee pursuant to Rule 457(h) under the Securities Act of 1933, as amended (the "Securities Act"), on the basis of the average of the high and low prices for the Common Stock on January 18, 2008.
(4)
Pursuant to Rule 429 under the Securities Act, a combined prospectus, relating to the 1,500,000 shares registered hereby and the 500,000 shares registered pursuant to the Registration Statement on Form S-8 (Registration No. 333-118303) filed with the Securities and Exchange Commission on August 17, 2004 relating to the Plan, (the "Prior Registration Statement"), will be delivered to Plan participants in accordance with Form S-8 and Rule 428 under the Securities Act.  (See "Explanatory Note.")
EXPLANATORY NOTE
The contents of Form S-8 Registration Statement No. 333-118303 relating to the Carrington Laboratories, Inc. (the "Registrant") 2004 Stock Option Plan, as amended (the "Plan"), and filed by the Registrant with the Securities and Exchange Commission on August 17, 2004 (the "Prior Registration Statement"), including all documents incorporated by reference in the Prior Registration Statement, are incorporated herein by reference pursuant to General Instruction E to Form S-8.
The purpose of this Registration Statement is to register 1,500,000 additional shares of Common Stock of the Registrant for offer and sale pursuant to the Plan.  Pursuant to Rule 429 under the Securities Act, this Registration Statement constitutes a post-effective amendment to the Prior Registration Statement, and a combined prospectus relating to the 1,500,000 shares of Common Stock registered pursuant to this Registration Statement and the 500,000 shares of Common Stock registered pursuant to the Prior Registration Statement will be delivered to Plan participants in accordance with Form S-8 and Rule 428 of the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Documents Incorporated by Reference
The contents of the Prior Registration Statement, including the documents incorporated by reference therein, are incorporated by reference in this Registration Statement.
Item 8.
Exhibits
In addition to the exhibits incorporated by reference to the exhibits filed with or incorporated by reference into the Prior Registration Statement, the exhibits listed in the accompanying Index to Exhibits are filed as a part of this Registration Statement.
[Signature Page Follows]
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Irving, State of Texas as of January 22, 2008.
CARRINGTON LABORATORIES, INC.
By:
/s/ Carlton E. Turner
Carlton E. Turner, Ph.D., D.Sc.
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.  The undersigned persons hereby constitute and appoint Carlton E. Turner and Robert W. Schnitzius, or either of them, as our true and lawful attorneys-in-fact with full power to execute in our names and on our behalf, in the capacities indicated below, any and all amendments to this Registration Statement and the Prior Registration Statement to be filed with the Securities and Exchange Commission and hereby ratify and confirm all that such attorneys-in-fact shall lawfully do or cause to be done by virtue hereof.
SIGNATURE
CAPACITY IN WHICH SIGNED
DATE
/s/ Carlton E. Turner
Carlton E. Turner,
Ph.D., D.Sc.
President, Chief Executor Officer and
Director (principal executive officer)
January 22, 2008
/s/ Robert W. Schnitzius
Robert W. Schnitzius
Chief Financial Officer and Secretary
(principal financial and accounting officer)
January 22, 2008
/s/ Ronald R. Blanck
Ronald R. Blanck, D.O.
Director
January 22, 2008
/s/ R. Dale Bowerman
R. Dale Bowerman
Director
January 22, 2008
/s/ George DeMott
George DeMott
Director
January 22, 2008
/s/ Thomas J. Marquez
Thomas J. Marquez
Director
January 22, 2008
/s/ Alex McPherson
Alex McPherson, M.D., Ph.D.
Director
January 22, 2008
/s/ Edwin Meese, III
Edwin Meese, III
Director
January 22, 2008
INDEX TO EXHIBITS
Exhibit Number
Exhibit
4.1
Carrington Laboratories, Inc. 2004 Stock Option Plan, as amended.
5.1
Opinion of Thompson & Knight L.L.P.
23.1
Consent of Weaver and Tidwell, L.L.P.
23.2
Consent of Grant Thornton LLP.
23.3
Consent of Thompson & Knight L.L.P. (included in Exhibit 5.1).
24.1
Power of Attorney (included on the signature page of this Registration Statement).